• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Orchestra BioMed Holdings, Inc. - Ordinary Shares (NQ:OBIO)

    4.365 -0.215 (-4.69%)
    Streaming Delayed Price Updated: 2:54 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 114,137
    Open 4.540
    Bid (Size) 4.360 (200)
    Ask (Size) 4.390 (100)
    Prev. Close 4.580
    Today's Range 4.305 - 4.700
    52wk Range 2.200 - 5.424
    Shares Outstanding 38,194,442
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Orchestra Biomed Holdings Inc (NASDAQ:OBIO) Fits the Minervini High-Growth Momentum Template ↗
    Via Chartmill
    News headline image
    Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +1.3%
    +1.3%
    1 Month
    -5.3%
    -5.3%
    3 Month
    +8.0%
    +8.0%
    6 Month
    +11.9%
    +11.9%
    1 Year
    +53.7%
    +53.7%

    More News

    Read More
    News headline image
    Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Host Business Update Call on November 12, 2025
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
    Via Benzinga
    News headline image
    Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Orchestra BioMed Holdings, Inc. - Ordinary Shares publicly traded?
    Yes, Orchestra BioMed Holdings, Inc. - Ordinary Shares is publicly traded.
    What exchange does Orchestra BioMed Holdings, Inc. - Ordinary Shares trade on?
    Orchestra BioMed Holdings, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares is OBIO on the Nasdaq Stock Market
    What is the current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 4.365
    When was Orchestra BioMed Holdings, Inc. - Ordinary Shares last traded?
    The last trade of Orchestra BioMed Holdings, Inc. - Ordinary Shares was at 04/20/26 02:54 PM ET
    What is the market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
    The market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 166.72M
    How many shares of Orchestra BioMed Holdings, Inc. - Ordinary Shares are outstanding?
    Orchestra BioMed Holdings, Inc. - Ordinary Shares has 167M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.